ACM
MDCO

Atika Capital Management’s Medicines Co MDCO Stock Holding History

Atika Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Hold
0
– -$1.06M – 111
2019
Q4 		– Sell
-52,100
Closed -$3.47M – 70
2019
Q3 		$2.6M Buy
52,100
+30,000
+136% +$1.2M 0.55% 56
2019
Q2 		$806K Buy
22,100
+6,900
+45% +$225K 0.16% 77
2019
Q1 		$425K Sell
15,200
-6,900
-31% -$163K 0.09% 72
2018
Q4 		$423K Sell
22,100
-160,400
-88% -$3.73M 0.12% 69
2018
Q3 		$5.46M Buy
182,500
+7,500
+4% +$283K 0.98% 35
2018
Q2 		$6.42M Buy
175,000
+159,000
+994% +$5.17M 1.24% 27
2018
Q1 		$527K Buy
+16,000
New +$500K 0.18% 70
2017
Q4 		– Sell
-20,000
Closed -$740K – 89
2017
Q3 		$740K Buy
+20,000
New +$737K 0.21% 76

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Atika Capital Management's MDCO Position: Q4 2019 in Review

Atika Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 124,000 shares — an estimated $8.27M sold.

Atika Capital Management first reported a position in MDCO in Q3 2016 and held it in 9 quarters. The position peaked at $7.22M in Q2 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Atika Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Atika Capital Management sold 124,000 Medicines Co shares in Q4 2019, an estimated $8.27M.
  • Atika Capital Management first reported a position in Medicines Co in Q3 2016 and held it in 9 quarters.
  • Atika Capital Management's Medicines Co position peaked at $7.22M in Q2 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.